Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II weekly ABI-007 plus gemcitabine in metastatic pancreatic cancer
jRCT2080221942Phase 2
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Oct 2012
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of nab-paclitaxel and gemcitabine in pancreatic cancer (PC), sponsored by Taiho Pharmaceutical Co., Ltd.
02
Drugs
nab-paclitaxelgemcitabine
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on jRCT2080221942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221942.